Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
SPOTLIGHT: Chantix scrips drop 5% on FDA alert
Prescriptions for Pfizer's stop-smoking drug Chantix dropped 5 percent last week after the FDA called it "increasingly likely" that there is a link between use of the drug and various neuro-psychiatric symptoms, including suicidal behavior. Report
Comments
It also makes you very angry,violent,with pain and swelling in the hands,feet knees,elbows basicaly in all the joints of the body.This starts AFTER you stop taking the medication!Not to mention the dreams. You will feel PURE RAGE and won't know why.This drug is very dangerous and needs to be studied more before giving it to the public.They should take it off the market immediately.You will be hearing a LOT more bad reports if they continue to give this drug to people and not moniter them.Sure it works but at what cost?
I did quit smoking on chantix.I quit it after 2 months.In the 3rd month was so suicidal admitted myself to hospital for my families sake .I didnt even care I was there.Currently months later have focal like seizures daily supposedly nonepileptic seizures.So taking this med think if the risk is worth the gain?I wish I had never taken it.
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage


